trending Market Intelligence /marketintelligence/en/news-insights/trending/SXZEtkEV0CJx5_TAR7BQbA2 content esgSubNav
In This List

Repros CEO resigns; interim CEO named

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Repros CEO resigns; interim CEO named

Joseph Podolski resigned as president, CEO and board member of Repros Therapeutics Inc. to pursue other interests.

Larry Dillaha, CEO of CavtheRx, has been appointed to serve as interim president and CEO, effective Feb. 2.